{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:53:29Z","timestamp":1773298409797,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,21]]},"DOI":"10.1093\/jnci\/djm224","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T01:43:01Z","timestamp":1195177381000},"page":"1695-1705","source":"Crossref","is-referenced-by-count":110,"title":["Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status"],"prefix":"10.1093","volume":"99","author":[{"given":"Rowan T.","family":"Chlebowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garnet L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy S.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron K.","family":"Aragaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shagufta","family":"Yasmeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Sarto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Allan","family":"Hubbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Women's Health Initiative Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,11,21]]},"reference":[{"key":"key\n\t\t\t\t20180328170526_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/dji128","article-title":"Cancer risk prediction models: a workshop on development, evaluation, and application","volume":"97","author":"Freedman","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib3","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2002.06.029","article-title":"American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene and aromatase inhibition","volume":"20","author":"Chlebowski","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180328170526_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-137-1-200207020-00017","article-title":"Chemoprevention of breast cancer: a summary of the evidence for the US preventive services task force","volume":"137","author":"Kinsinger","year":"2002","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180328170526_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","article-title":"Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention","volume":"95","author":"Freedman","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cncr.20882","article-title":"Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits","volume":"103","author":"Brewster","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180328170526_bib7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.164.17.1897","article-title":"Breast cancer risk in primary care: implications for chemoprevention","volume":"164","author":"Lewis","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180328170526_bib8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the Women's Health Initiative study design","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20180328170526_bib9","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","article-title":"The Women's Health Initiative recruitment methods and results","volume":"13","author":"Hays","year":"2003","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20180328170526_bib10","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S1047-2797(03)00047-4","article-title":"The Women's Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures","volume":"13","author":"Langer","year":"2003","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20180328170526_bib11","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"WHI Morbidity and Mortality Committee. Outcomes ascertainment and adjudication methods in the Women's Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20180328170526_bib12","article-title":"About SEER","author":"National Cancer Institute"},{"key":"key\n\t\t\t\t20180328170526_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180328170526_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/86.8.620","article-title":"Validation of a breast cancer risk assessment model in women with a positive family history","volume":"86","author":"Bondy","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a114942","article-title":"The evaluation of the data collection process for a multicenter, population-based case-control design","volume":"128","author":"Wingo","year":"1988","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180328170526_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jnci\/86.8.600","article-title":"Validation of the Gail et al. model for predicting individual breast cancer risk","volume":"86","author":"Spiegelman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/jnci\/91.23.2020","article-title":"Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers","volume":"91","author":"Porter","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djh025","article-title":"Risk factors for breast cancer according to estrogen and progesterone receptor status","volume":"96","author":"Colditz","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacr.2006.03.025","article-title":"Current practice patterns and recent trends in breast biopsy among radiologists and surgeons","volume":"3","author":"Levin","year":"2006","journal-title":"J Am Coll Radiol"},{"key":"key\n\t\t\t\t20180328170526_bib22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.165.14.1593","article-title":"Breast biopsy utilization","volume":"165","author":"Ghosh","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180328170526_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1525","article-title":"Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies","volume":"8","author":"Ma","year":"2006","journal-title":"Breast Cancer Res"},{"key":"key\n\t\t\t\t20180328170526_bib24","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1055-9965.EPI-06-0489","article-title":"Risk factors for hormone receptor-defined breast cancer in postmenopausal women","volume":"15","author":"Rosenberg","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20180328170526_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ncponc0851","article-title":"Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer","volume":"4","author":"Chen","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"key\n\t\t\t\t20180328170526_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1055-9965.EPI-04-0758","article-title":"Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups","volume":"15","author":"Kaplan","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20180328170526_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0162243904264960","article-title":"Constructing \u201chigh risk women\u201d: the development and standardization of a breast cancer risk assessment tool","volume":"29","author":"Fosket","year":"2004","journal-title":"Sci Technol Human Values"},{"key":"key\n\t\t\t\t20180328170526_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jnci\/djm032","article-title":"Researchers wonder why high-risk women are not taking chemoprevention drugs [news]","volume":"99","author":"Savage","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib29","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.166.20.2260","article-title":"Prescription of tamoxifen for breast cancer prevention by primary care physicians","volume":"166","author":"Armstrong","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180328170526_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/dji128","article-title":"Cancer risk prediction models: a workshop on development, evaluation, and application","volume":"97","author":"Freedman","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib31","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/jnci\/dji346","article-title":"Ethnicity and breast cancer: factors influencing differences in incidence and outcome","volume":"97","author":"Chlebowski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.11018","article-title":"Breast cancer risk assessment models: applicability to African American women","volume":"97","author":"Bondy","year":"2003","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180328170526_bib33","volume-title":"Proposed revision of the Gail breast cancer risk assessment model for African American women","author":"Newman","year":"2003"},{"key":"key\n\t\t\t\t20180328170526_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1524-4741.2007.00439.x","article-title":"Diagnostic accuracy of the Gail model in the Black Women's Health Study","volume":"13","author":"Adams-Campbell","year":"2007","journal-title":"Breast J"},{"key":"key\n\t\t\t\t20180328170526_bib35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib36","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen versus raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328170526_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328170526_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1056\/NEJMra035692","article-title":"Benign breast disorders","volume":"353","author":"Santen","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328170526_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-143-6-200509200-00009","article-title":"Premalignant and in situ breast disease: biology and clinical implications","volume":"143","author":"Arpino","year":"2005","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180328170526_bib40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"The Endogenous Hormones and Breast Cancer Collaborative Group","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328170526_bib42","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.1996.03540170048031","article-title":"Bone mineral density and risk of breast cancer in older women:the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group","volume":"276","author":"Cauley","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328170526_bib43","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jnci\/djm062","article-title":"Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women","volume":"99","author":"Tamimi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jama.287.2.216","article-title":"Multiple Outcomes of Raloxifene Evalution (MORE) Trial. Serum estradiol level and risk of breast cancer during treatment with raloxifene","volume":"287","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328170526_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnci\/djj011","article-title":"Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1)","volume":"98","author":"Beattie","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-005-5152-4","article-title":"Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population","volume":"94","author":"Tice","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20180328170526_bib47","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djj331","article-title":"Prospective breast cancer risk prediction model for women undergoing screening mammography","volume":"98","author":"Barlow","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328170526_bib48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djj332","article-title":"Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density","volume":"98","author":"Chen","year":"2006","journal-title":"J Natl Cancer Inst"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/99\/22\/1695\/18614964\/djm224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T06:05:11Z","timestamp":1522303511000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/99\/22\/1695\/961269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":48,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2007,11,21]]},"published-print":{"date-parts":[[2007,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djm224","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,11]]},"published":{"date-parts":[[2007,11]]}}}